John Libbey Eurotext

VEGF Actu

Bases moléculaires de la réponse immunitaire cellulaire contre les tumeurs Volume 11, issue 2, Avril 2016

  • [1] Finn OJ. Cancer immunology. N Engl J Med. 2008;358:2704-15.
  • [2] Schumacher TN, Schreiber RD. Neoantigens in cancer immunotherapy. Science. 2015;348:69-74.
  • [3] Chen DS, Mellman I. Oncology meets immunology: the cancer-immunity cycle. Immunity. 2013;39:1-10.
  • [4] Postow MA, Chesney J, Pavlick AC. Nivolumab and ipilimumab versus ipilimumab in untreated melanoma. N Engl J Med. 2015;372:2006-17.
  • [5] Borghaei H, Paz-Ares L, Horn L. Nivolumab versus docetaxel in advanced nonsquamous non-small-cell lung cancer. N Engl J Med. 2015;373:1627-39.